ProcartaPlex™ Human Neurodegeneration Panel 1, 9plex - Citations

ProcartaPlex™ Human Neurodegeneration Panel 1, 9plex - Citations

View additional product information for ProcartaPlex™ Human Neurodegeneration Panel 1, 9plex - Citations (EPX090-15836-901)

Showing 2 product Citations

Citations & References
Abstract
Characterization and Biomarker Analyses of Post-COVID-19 Complications and Neurological Manifestations.
AuthorsSun B,Tang N,Peluso MJ,Iyer NS,Torres L,Donatelli JL,Munter SE,Nixon CC,Rutishauser RL,Rodriguez-Barraquer I,Greenhouse B,Kelly JD,Martin JN,Deeks SG,Henrich TJ,Pulliam L
JournalCells
PubMed ID33668514
As the SARS-CoV-2 pandemic continues, reports have demonstrated neurologic sequelae following COVID-19 recovery. Mechanisms to explain long-term neurological sequelae are unknown and need to be identified. Plasma from 24 individuals recovering from COVID-19 at 1 to 3 months after initial infection were collected for cytokine and antibody levels and neuronal-enriched ... More
Blood Markers Show Neural Consequences of Long COVID-19.
AuthorsTang N,Kido T,Shi J,McCafferty E,Ford JM,Dal Bon K,Pulliam L
JournalCells
PubMed ID38534322
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) persists throughout the world with over 65 million registered cases of survivors with post-COVID-19 sequelae, also known as LongCOVID-19 (LongC). LongC survivors exhibit various symptoms that span multiple organ systems, including the nervous system. To search for neurological markers of LongC, we investigated ... More